COO - coopercos.com Profit before interest, taxes and amortization
Regulatory hurdles and currency volatility are constraining the expansion of The Cooper Companies (COO), as reflected in the financial EBITDA trend, which has reached 1189.49. Profit stability is underpinned by the low demand elasticity for optics and the uniqueness of the company's women's products. Business efficiency is further enhanced by the compact nature of the goods, enabling the use of low-cost, rapid air freight globally.
CooperCompanies (COO) - metric breakdowns and financial figures
- share price and consensus valuation forecast:
- market capitalization statistics:
- book capitalization data:
- business debt structure and liquidity details:
Total Debt to Equity Ratio The Cooper Companies|COO - Long-Term Debt to Capital|Current Liabilities to Capital The Cooper Companies, Inc.|COO - Company Aggregate Debts|Debt to Book Value Ratio CooperCompanies|COO - Company Long-Term Debts|Short-Term Debt Volume CooperCompanies|Quick Liquidity Indicator coopercos.com
- earnings and valuation multiples indicators:
COO - Net Profit|Projected Future Earnings The Cooper Companies|COO - Price to Earnings Ratio|Future Price to Earnings coopercos.com|COO - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation CooperCompanies|COO - Operating profit EBITDA|Net earnings per one share for the last twelve months CooperCompanies|COO - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year coopercos.com|COO - Net earnings per share growth this year|Earnings growth forecast for next year The Cooper Companies
Summary company analytics:CooperSurgical - COO
This metric is calculated as the difference between operating income and expenses, excluding depreciation and amortization. The metric captures the actual cash flow from core operations before taxes and interest. For The Cooper Companies (COO), this reflects the synergy between the lens business and women's health tools. Stable growth confirms the effectiveness of asset diversification. By analyzing the projected EBITDA level, an investor determines the long-term development vector of the business.
Who The Cooper Companies competes with
BSX (Boston Scientific Corporation Inc.) - Profit before deduction of interest, taxes, depreciation and amortization|Edwards Lifesciences - Operating profit EBITDA|Profit before interest, taxes and amortization resmed.com|PODD: Operating profit EBITDA|Operating profit before amortization ZBH|Operating profit before deduction of amortization ALGN|GMED: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization TransMedics (TMDX)|Operating profit before deduction of amortization atecspine.com ATEC|Operating profit EBITDA AORT (Artivion)|Enovis Corp (ENOV) - Profit before interest, taxes and amortization|Integra - Operating profit EBITDA|ESTA (Establishment Labs Inc) - Operating profit before amortization|BBNX: Operating profit EBITDA|IRMD - Operating income before deduction of amortization|EMBC (Embecta) - Operating profit EBITDA|Operating profit before deduction of amortization Tandem Diabetes Care Inc (TNDM)|Operating profit EBITDA AXGN|Operating profit EBITDA SI-BONE Medical (SIBN)|Profit before payment of interest, taxes and amortization Orthofix Medical Inc. OFIX|bioventus.com - Profit before payment of interest, taxes and amortization|KIDS: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization TMCI (Treace Medical Concepts Inc)|SRTA: Operating profit EBITDA|Profit before interest, taxes and amortization Carlsmed Medical (CARL)|Profit before payment of interest, taxes and amortization RxSight, Inc.|CLPT - Operating profit before depreciation charges|Operating profit before deduction of amortization STXS (Stereotaxis)|Operating profit EBITDA Neuronetics Inc. (STIM)|Operating profit EBITDA SGHT (Sight Sciences, Inc)|Operating income before deduction of amortization orchestrabiomed.com (OBIO)|ANIK - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization NSPR|zhjmedical.com (ZJYL) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Vivani Medical|XTNT (Xtant Medical Holdings, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization NeuroOne Medical Technologies Corp. NMTC|Profit before payment of interest, taxes and amortization Modular Medical (MODD)|myomo.com - Operating profit before amortization|Envoy Medical - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization VVOS (Vivos Therapeutics Inc.)|NVNO: Operating profit before deduction of amortization|Sintx Technologies - Company profit before taxes, interest and amortization|TNON: Operating profit EBITDA|rewalk.com - Income before deduction of interest, taxes and amortization|AMIX (Autonomix Medical Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization INVO Bioscience IVF|Operating profit before deduction of amortization BBLG (Bone Biologics Corporation)|AXNX (Axonics, Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA BIOL (BIOLASE, Inc.)|DYNT - Operating profit before deduction of amortization|FNA - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization INVO Bioscience, Inc.
